Thymosin Alpha-1
Tα1, 28-residue thymic peptide
A 28-amino-acid N-terminally acetylated thymic peptide studied extensively in immune modulation and T-cell maturation models.
Current lot verified
CP-THYMOSO9-2607A · tested Jul 24, 2026
98.62 %
HPLC purity
About Thymosin Alpha-1
Thymosin alpha-1 is a 28-residue peptide originally isolated from thymic tissue, N-terminally acetylated, with a highly acidic character. Its research history is longer and better documented than most compounds in this catalogue — it has been through formal clinical investigation in several jurisdictions and the immunological mechanism is comparatively well mapped, centring on TLR signalling and dendritic cell maturation with downstream effects on T-cell differentiation.
Synthesis quality matters here because the sequence is long, acidic and contains multiple aspartate and glutamate residues prone to side reactions during chain assembly. Aspartimide formation is the specific failure mode: it produces a same-mass isomer that LC-MS alone will not catch. We use an orthogonal HPLC gradient specifically selected to resolve the aspartimide isomer, and the chromatogram is on the certificate.
Published research areas
- T-cell maturation models
- TLR and innate immune signalling
- Dendritic cell research
- Immune modulation studies
Specifications
- CAS number
- 62304-98-7
- Molecular formula
- C129H215N33O55
- Molecular weight
- 3108.30 g/mol
- Release specification
- ≥ 98.0 % by HPLC
- Appearance
- White lyophilised cake
- Solubility
- Soluble in water; solutions are mildly acidic
- Storage
- -20 °C lyophilised, desiccated
- Format
- lyophilized vial
Handling and reconstitution
Reconstitute in sterile water rather than saline — high ionic strength reduces solubility for this acidic sequence.
Storage: -20 °C lyophilised, desiccated
Full reconstitution and storage referenceLot history
Every released lot of this compound, oldest kept on file. Average across 2 lots: 98.47 %.
| Lot | Strength | Purity | Tested | Laboratory | |
|---|---|---|---|---|---|
| CP-THYMOSO9-2607A | 5 mg | 98.62 % | Jul 24, 2026 | Aurum Bioanalytics | Certificate → |
| CP-THYMOSO9-2605B | 10 mg | 98.32 % | May 13, 2026 | Aurum Bioanalytics | Certificate → |



